Tenderwize
Back to tender search

Aflibercept (40 mg/ml)

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha·Praha 6, Czech Republic·CZK 50.1M | EUR 2.1M·Deadline Sep 15, 2026 · 30 days left·Open·Supplies
High valueStructured notice only
Original notice title

Czechia – Ophthalmologicals – Aflibercept (40 mg/ml)

55/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

25 / 100

Risk factors

Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.

Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • CZK 50.1M estimated value
  • Supplies contract
  • 1 lot
  • Duration 48 MONTH
  • Continuous supplies of Aflibercept (40 mg/ml) for 48 months.
  • Delivery to Central Military Hospital – Military University Hospital Prague.
Show full summary

Open tender by Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha for continuous supplies of the medicinal product with active substance Aflibercept (40 mg/ml) for a period of 48 months. The estimated value is 50,148,102.56 CZK. Award based on lowest price. No selection criteria or procurement documents provided in the analysis.

Risks

Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.

Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Pharmaceutical product with active substance Aflibercept at concentration 40 mg/ml.
  • Contract duration 48 months.
  • EU-funded project (conflicting: XML notice states no EU funds).

Requirements may be incomplete.

Award Criteria

Lot 1

Lowest price (weight 100)100%

Buyer

Location

Praha 6, CZE

Website

www.uvn.cz

Buyer profile

Open profile

Identifier

61383082

Activity

Health

Lots (1)

LOT-0001

Aflibercept (40 mg/ml)

Continuous supplies of Aflibercept (40 mg/ml) for the Central Military Hospital – Military University Hospital Prague.

SuppliesEU fundedElectronic submission

EUR 2.1M

Estimated value

Location

CZ010, Czech Republic

Duration

48 MONTH

Category

Ophthalmologicals

Award Criteria

Price

Deadline

Deadline Sep 15, 2026

Procurement Details

Publication date
09 Jul 2026
Languages
Czech

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
477378-2026

Documents (1)

Similar tenders